With several vaccines approved, 2021 started with a significant dose of optimism. Given the complexity of rolling out a mass vaccination program, the spread of a new coronavirus strain, and renewed movement restrictions, 2021’s prospects are already looking as uncertain as those of 2020. This survey captured company perspectives on COVID-19 vaccine planning, logistics, and distribution to employees during February and March of 2021.